Comorbidity in refractory asthma : cost of illness and economic impact of systemic steroid exposure in the UK
Patients with refractory asthma represent a significant unmet clinical need where treatment options are limited and effective management poses a challenge. Treatment with daily systemic corticosteroids is the norm for many patients. Subsequently they are at risk of many significant and potentially l...
| Main Author: | |
|---|---|
| Published: |
Queen's University Belfast
2015
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.676707 |